Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 2,544,000 | 2,508,500 | 2,589,100 | 2,531,800 | 2,733,801 |
| Cost of Goods | 570,900 | 469,500 | 484,000 | 753,900 | 660,100 |
| Gross Profit | 1,973,100 | 2,039,000 | 2,105,100 | 1,777,900 | 2,073,701 |
| Operating Expenses | 1,257,100 | 724,400 | 1,264,200 | 1,168,100 | 1,486,700 |
| Operating Income | 716,900 | 1,315,100 | 840,900 | 610,700 | 587,100 |
| Other Income | -113,100 | 56,000 | 434,500 | -266,600 | -164,400 |
| Pre-tax Income | 603,800 | 1,371,100 | 1,275,400 | 344,100 | 422,700 |
| Income Tax | 54,300 | 236,200 | 216,700 | 125,600 | 443,300 |
| Net Income Continuous | 549,500 | 1,134,900 | 1,058,700 | 218,500 | -20,600 |
| Minority Interests | -900 | 200 | 700 | -85,300 | -388,800 |
| Net Income | $550,400 | $1,134,700 | $1,058,000 | $303,800 | $368,200 |
| EPS Basic Total Ops | 3.79 | 7.86 | 7.25 | 2.06 | 2.52 |
| EPS Basic Continuous Ops | 3.78 | 7.86 | 7.26 | 1.49 | -0.08 |
| EPS Diluted Total Ops | 3.73 | 7.84 | 7.24 | 2.06 | 2.50 |
| EPS Diluted Continuous Ops | 3.73 | 7.84 | 7.24 | 1.48 | -0.08 |
| EPS Diluted Before Non-Recurring Items | 4.05 | 4.77 | 5.25 | N/A | N/A |
| EBITDA(a) | $956,300 | $1,435,800 | $975,700 | $753,800 | $721,801 |